Affiliated Managers Group, Inc. (MGRB) |
|
21.67 0.08 (0.37%)
|
08-14 11:25 |
|
Open: |
21.66 |
Pre. Close: |
21.59 |
|
High:
|
21.68 |
Low:
|
21.47 |
|
Volume:
|
9,607 |
Market Cap:
|
0(M) |
|
|
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
21.71 - 21.79 |
21.79 - 21.87 |
|
Low:
|
21.25 - 21.35 |
21.35 - 21.45 |
|
Close:
|
21.51 - 21.66 |
21.66 - 21.82 |
|
Technical analysis |
as of: 2022-08-12 4:23:46 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 25.73 One year: 30.06 |
| Support: |
Support1: 20.38 Support2: 19.36 |
| Resistance: |
Resistance1: 22.03 Resistance2: 25.73 |
| Pivot: |
21.2 |
| Moving Average: |
MA(5): 21.57 MA(20): 20.89
MA(100): 20.25  MA(250): 23.13 |
| MACD: |
MACD(12,26): 0.4 Signal(9): 0.4 |
| Stochastic oscillator: |
%K(14,3): 78.2 %D(3): 77.1 |
| RSI: |
RSI(14): 67.3 |
| 52-week: |
High: 26.81 Low: 18.44 |
| Average Vol(K): |
3-Month: 28 (K) 10-Days: 17 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ MGRB ] has closed below upper band by 30.9%. Bollinger Bands are 31.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 28 Jul 2022
High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy | Scientific Reports - Nature.com
Mon, 02 May 2022
Affiliated Managers Group's (AMG) CEO Jay Horgen on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha
Mon, 11 Apr 2022
Lung Cancer Patients With Variant of the CTLA-4 Gene May Respond Better to Immunotherapy - Technology Networks
Mon, 20 Dec 2021
Leveraging cell-type-specific regulatory networks to interpret genetic variants in abdominal aortic aneurysm | Proceedings of the National Academy of Sciences - pnas.org
Fri, 24 Jan 2020
Genome Reference Database Published on Healthy Elderly Individuals - Genetic Engineering & Biotechnology News
Wed, 31 Dec 1969
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: |
| Industry: |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2021-12-29 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
